SOMS-GCS: Influence of the Initial Level of Consciousness on Early, Goal-directed Mobilization

Sponsor
Technische Universität München (Other)
Overall Status
Completed
CT.gov ID
NCT03666338
Collaborator
Massachusetts General Hospital (Other), Università degli Studi di Brescia (Other), Beth Israel Deaconess Medical Center (Other)
200
2
54.8

Study Details

Study Description

Brief Summary

Analysis of the randomized controlled SOMS trial of early, goal-directed mobilization to investigate if the treatment effect is consistent and independent of the initial conscious state without evidence of moderation or modification.

Condition or Disease Intervention/Treatment Phase
  • Other: Early, goal-directed mobilization
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Influence of the Initial Level of Consciousness on Early, Goal-directed Mobilization
Actual Study Start Date :
Jul 11, 2011
Actual Primary Completion Date :
Nov 4, 2015
Actual Study Completion Date :
Feb 4, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Early, goal-directed mobilization

Early goal-directed mobilization with (1) SOMS algorithm and (2) facilitator

Other: Early, goal-directed mobilization
Early, goal directed mobilization using (1) the SOMS algorithm and (2) facilitator

No Intervention: Standard of Care

Standard of Care regarding mobilization

Outcome Measures

Primary Outcome Measures

  1. Functional independence at hospital discharge [At the day of hospital discharge, on average up to 1 month]

    minimal modified functional independence measure score of 8 (Scale ranging from 0-8 with the subdomain locomotion and transfer 0-4 each)

Secondary Outcome Measures

  1. average achieved mobility level during the ICU stay [from ICU admission to ICU discharge, on average up to 2 weeks]

    mean achieved SOMS level

  2. Functional status at hospital discharge [At the day of hospital discharge, on average up to 1 month]

    minimal modified functional independence measure score (range 0-8) of the subdomains transfer and locomotion with 0-4 each

  3. Start to mobilization (SOMS > 0) [Days from ICU admission till first mobilization, approximately up to 5 days]

    Start to mobilization in days (Surgical Optimal Mobilization Scale > 0, ranging from 0 = no mobilization to 4 ambulation)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • aged 18 years or older

  • mechanically ventilated for less than 48 h and expected to require mechanical ventilation for at least another 24 h at the time of screening

  • functionally independent at baseline with a Barthel Index Score of at least 70 at 2 weeks before admission to the ICU based on patient or proxy completion of the measure

Exclusion Criteria:
  • admitted to hospital for more than 5 days before screening

  • a motor component of Glasgow Coma Scale (GCS) lower than 5

  • irreversible disorder with a 6-month mortality of greater than 50%,

  • raised intracranial pressure

  • cardiopulmonary arrest

  • unstable fractures contributing to probable immobility

  • inclusion in another trial at the same time

  • acute myocardial infarction

  • do not have lower part of their legs

  • have a rapidly developing neuromuscluar disease

  • pregnant

  • ruptured or leaking aortic aneurysm

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Technische Universität München
  • Massachusetts General Hospital
  • Università degli Studi di Brescia
  • Beth Israel Deaconess Medical Center

Investigators

  • Principal Investigator: Matthias Eikermann, MD, Beth Israel Deaconess Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Stefan Schaller, Specialist Intensive Care, Technische Universität München
ClinicalTrials.gov Identifier:
NCT03666338
Other Study ID Numbers:
  • SOMS-GCS
First Posted:
Sep 11, 2018
Last Update Posted:
Sep 13, 2018
Last Verified:
Sep 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Stefan Schaller, Specialist Intensive Care, Technische Universität München

Study Results

No Results Posted as of Sep 13, 2018